focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,128.00
Bid: 12,126.00
Ask: 12,128.00
Change: -44.00 (-0.36%)
Spread: 2.00 (0.016%)
Open: 12,180.00
High: 12,188.00
Low: 12,076.00
Prev. Close: 12,172.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Barclays Cuts Travis Perkins To Underweight

Thu, 11th Aug 2016 08:35

LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning and Wednesday:
----------
FTSE 100
----------
BARCLAYS CUTS TRAVIS PERKINS TO 'UNDERWEIGHT' ('EQUALWEIGHT') - TARGET 1400 (1950) PENCE
----------
LIBERUM ADDS BRITISH LAND TO 'CONVICTION SELL LIST'
----------
COMMERZBANK CUTS EASYJET PRICE TARGET TO 1200 (1350) PENCE - 'HOLD'
----------
JPMORGAN CUTS RBS PRICE TARGET TO 175 (185) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN CUTS LLOYDS PRICE TARGET TO 62 (65) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS BARCLAYS PRICE TARGET TO 175 (180) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES ROLLS ROYCE GROUP PRICE TARGET TO 835 (730) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES PEARSON PRICE TARGET TO 935 (905) PENCE - 'NEUTRAL'
----------
EXANE BNP RAISES BHP BILLITON PRICE TARGET TO 900 (885) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES COMPASS GROUP PRICE TARGET TO 1378 (1324) PENCE - 'NEUTRAL'
----------
BERENBERG RAISES ASTRAZENECA PRICE TARGET TO 5600 (5400) PENCE - 'BUY'
----------
HSBC CUTS ASTRAZENECA PRICE TARGET TO 4700 (4815) PENCE - 'HOLD'
----------
FTSE 250
----------
LIBERUM REMOVES TULLOW OIL FROM 'CONVICTION SELL LIST'
----------
PANMURE CUTS CENTAMIN TO 'HOLD' ('BUY') - TARGET 168 (145) PENCE
----------
RBC CAPITAL RAISES CENTAMIN PRICE TARGET TO 190 (170) PENCE - 'SECTOR PERFORM'
----------
Numis Ups Centamin Target To 180p From 160p, Keeps Hold
----------
HSBC RAISES SEGRO PRICE TARGET TO 418 (378) PENCE - 'HOLD'
----------
HSBC CUTS BRITVIC PRICE TARGET TO 620 (640) PENCE - 'HOLD'
----------
Investec Ups Virgin Money Target To 375p From 360p, Keeps Buy
----------
Cantor Cuts Debenhams Target To 60p From 70p, Keeps Hold
----------
Liberum Ups Spirax-Sarco Target To 4,090p From 3,140p, Keeps Hold
----------
MORGAN STANLEY RAISES SPIRAX-SARCO TARGET TO 4080 (3570) PENCE - 'EQUAL-WEIGHT'
----------
S&P GLOBAL RAISES AMEC PRICE TARGET TO 600 (500) PENCE - 'BUY'
----------
TRADERS: CANACCORD CUTS ENTERTAINMENT ONE TO 'HOLD' ('BUY')
----------
BERENBERG RAISES INMARSAT PRICE TARGET TO 910 (880) PENCE - 'HOLD'
----------
MAIN MARKET AND AIM
----------
RBC CAPITAL CUTS FAROE PETROLEUM PRICE TARGET TO 100 (120) PENCE - 'OUTPERFORM'
----------
JPMORGAN RAISES INTERSERVE PRICE TARGET TO 425 (416) PENCE - 'OVERWEIGHT'
----------
finnCap Initiates Joules Group With Buy, Target At 200p
----------
Berenberg Ups Benchmark Holdings Target To 80p From 70p, Keeps Buy
----------
BERENBERG RAISES STOCK SPIRITS PRICE TARGET TO 150 (137) PENCE - 'HOLD'
----------
BERENBERG CUTS LOOKERS PRICE TARGET TO 170 (220) PENCE - 'BUY'
----------
BERENBERG RAISES GVC HOLDING PRICE TARGET TO 760 (730) PENCE - 'BUY'
----------
BERENBERG RAISES STAFFLINE TO 'BUY' ('HOLD') - TARGET 1250 (900) PENCE
----------
Numis Ups Breedon Aggregates to Add From Hold, Target To 82p From 70p
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
Today 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.